REGN

URI: https://gptkb.org/entity/REGN
GPTKB entity
Statements (27)
Predicate Object
gptkbp:instance_of gptkb:biotechnology
gptkbp:acquisition gptkb:Aclaris_Therapeutics
gptkb:Checkmate_Pharmaceuticals
gptkbp:awards gptkb:Nobel_Prize_in_Physiology_or_Medicine_(2018)
gptkbp:ceo gptkb:Leonard_Schleifer
gptkbp:clinical_trial multiple ongoing
gptkbp:collaboration gptkb:Mount_Sinai_Health_System
gptkb:University_of_Pennsylvania
gptkbp:employees approximately 3,000
gptkbp:focus biopharmaceuticals
gptkbp:founded gptkb:1988
gptkbp:founder gptkb:Leonard_Schleifer
gptkbp:headquarters gptkb:Tarrytown,_New_York
https://www.w3.org/2000/01/rdf-schema#label REGN
gptkbp:notable_products gptkb:Repatha
gptkb:Dupixent
gptkb:Eylea
gptkbp:partnership gptkb:Astra_Zeneca
gptkb:Sanofi
gptkbp:research_focus monoclonal antibodies
gptkbp:revenue $8.5 billion (2022)
gptkbp:stock_symbol gptkb:REGN
gptkbp:traded_on gptkb:NASDAQ
gptkbp:website www.regeneron.com
gptkbp:bfsParent gptkb:Regeneron_Pharmaceuticals
gptkb:Regeneron
gptkbp:bfsLayer 4